Quick Answer
XBiotech Inc. reported Diluted EPS of $0.81 per share (loss) for fiscal year 2023.
XBiotech Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.81 | +25.0% |
| 2022 | -$1.08 | -86.2% |
| 2021 | -$0.58 | -61.1% |
| 2020 | -$0.36 | -102.5% |
| 2019 | $14.44 | +2547.5% |
| 2018 | -$0.59 | +37.9% |
| 2017 | -$0.95 | — |
- XBiotech Inc. showed an increase of +25.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2017–2023 period, XBiotech Inc.’s diluted eps has grown by 14.7% (from $0.95 per share (loss) to $0.81 per share (loss)).
- The most recent figure is from XBiotech Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 15, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: